Insights
AsclepiX Therapeutics logo

AsclepiX Therapeutics

1 Follower

About

AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, and delivery of novel peptides with the power to inhibit proven key disease pathways. Our peptide drug candidates tap into the body’s powerful mechanisms of maintaining homeostasis, the fundamental principle of biology to seek and maintain a condition of equilibrium or stability.

Aleksander S. Popel
Aleksander S. Popel
Vice President, Research and Development
Ben Askew
Ben Askew
Director
Huan Sheng
Huan Sheng
Vice President, Clinical Research
Jordan J. Green
Jordan J. Green
Founder, Chief Technology Advisor
Niranjan B. Pandey
Niranjan B. Pandey
Vice President, Research and Development
Quan D. Nguyen
Quan D. Nguyen
Clinical Drug Safety Advisor
Theresa Heah
Theresa Heah
Chief Medical Officer, Executive Vice President, Operations

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.